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Background: People vary in how they respond to symptoms. The purpose of this study was to assess whether
serious disease is more likely to be present in patients who report that they take any symptoms less seriously than
other people do, and to assess the reliability of a question which can be used to identify the extent to which
patients take any symptom seriously. To do this we assessed whether the likelihood of detecting colorectal cancer
is higher in patients who report that they take symptoms less seriously than other people do.
Methods: Cross sectional study of 7736 patients who had colonoscopy to find colorectal cancer. Before
colonoscopy, patients completed a questionnaire on bowel symptoms and were also asked: “Compared to other
people of your age and sex, how seriously do you think you take any symptoms?” Likelihood of detecting
colorectal cancer according to responses to this question was assessed by logistic regression models, unadjusted
and adjusted for symptoms and other known predictors of colorectal cancer.
Question reliability was assessed in a different sample using percentage agreement and the kappa statistic for the
answers given by each patient on two occasions. Agreement between patient and doctor responses was also
assessed (n = 108).
Results: Patients who reported they took symptoms less seriously were 3.28 (95%CI: 2.02, 5.33) times more likely to
have colorectal cancer than patients who took symptoms more seriously than others. The effect was smaller (1.85
(95%CI: 1.11, 3.09)), but remained statistically significant in models including symptoms and other predictors of
colorectal cancer. The question was reliable: on repeat questioning, 70% of responses were in absolute agreement
and 92% were within 1 category, kappa 57%. Patient-doctor agreement was 66%, within 1 category 92%, kappa
48%.
Conclusion: Patients who take their symptoms less seriously have a considerably higher likelihood of colorectal
cancer than those who identify themselves as taking any symptoms more seriously than other people. The
question is easy to ask and has good reliability. Doctors also reliably identify how patients assess themselves.
Assessment of how seriously patients take any symptoms can contribute to the clinical assessment of a patient.
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People vary in how they respond to symptoms. Some
may not take symptoms seriously while others may be-
come concerned about even minor symptoms. Individual
perceptions about the seriousness of symptoms may
affect decisions to consult a health practitioner. People
who take symptoms seriously are probably more likely
to ask for medical help at a symptom severity which* Correspondence: b.adelstein@unsw.edu.au
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reproduction in any medium, provided the orwould prompt no action by someone who takes their
symptom less seriously.
There is surprisingly little research on the variability in
how seriously people take their symptoms or how this is
associated with clinical outcomes. Research has explored
factors influencing people to seek medical attention
[1,2], and it is accepted that patients’ knowledge, beliefs
and expectations about an illness determines their ap-
praisal of their symptoms, illness and subsequent health
behaviour [3,4]. It has been suggested that patients abil-
ity to “detect” their symptoms – to know whichal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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nosis – is associated with seeking medical advice in a
timely manner [5,6]. It has been demonstrated that
patients cope with adverse events, including experien-
cing symptoms, differently depending on their coping
style [7]. Anxiety [8] and personality type [9] influence
people’s decision to seek medical help. Some health
seeking behaviour research has been concerned with
‘worry’ which often overlaps with risk perception.
Worry has been shown to be associated with test
results indicative of pathology. For example, in men
undergoing screening for prostate cancer, worry about
having the disease was associated with a higher
prostate-specific antigen (PSA), even after controlling
for other factors such as perceived cancer risk, and
cancer–related symptoms [10]. However, there is a
dearth of research on whether how seriously a person
takes their symptoms is associated with a finding of
serious disease, such as colorectal cancer.
Further, while there are several questionnaires that
evaluate issues related to how seriously people take
symptoms [11], each tests only one specific aspect of a
complex issue, and each comprises several questions.
There is no single, simple measure. The absence of such
a simple reliable tool hinders research about whether
patients who take their symptoms seriously present earl-
ier in the course of disease or have less serious under-
lying illness.
Our aim was to assess whether serious disease is more
likely to be present in patients who report that they take
any symptoms less seriously than other people do, and to
assess the reliability of a question which can be used to
identify the extent to which patients take any symptom ser-
iously. These objectives were addressed using data from the
CRISP (Colonoscopy Research in Symptom Prediction)
study [12,13]. We investigated whether the seriousness with
which a patient takes their symptoms is predictive of a find-
ing of colorectal cancer on colonoscopy, both unadjusted
and also adjusted for variables that were included in a mul-
tivariable prediction model previously developed using
CRISP data [12,13].
Methods
The CRISP study was a cross sectional study of 7736
patients aged over 18 years who were scheduled to
undergo colonoscopy (see Adelstein [12] for a detailed
description of the methods of this study). Prior to colon-
oscopy, patients were asked to complete a comprehen-
sive self-administered questionnaire that elicited data
relating to their bowel symptoms, socio-demographic
characteristics, medical and family history, use of aspirin
and other non-steroidal anti-inflammatory medications,
and previous colonoscopy. The questionnaire has previ-
ously been shown to be repeatable within patient andbetween patient and doctor [14], and a copy is available
electronically via the publication website. Findings at
colonoscopy were collated from endoscopic records. All
cancers diagnosed were confirmed by histology.
The questionnaire contained an item relating to symp-
tom perception: “Compared to other people of your age
and sex, how seriously do you think you take any symp-
toms?” The five possible answers were: a lot less
seriously than other people; less seriously than other
people; about the same as other people; more seriously
than other people; and a lot more seriously than other
people. Methods for assessing whether responses to this
question were associated with colorectal cancer, and also
the repeatability of the question are outlined below.
Assessment of predictive validity
In keeping with our published investigation of the as-
sociation between bowel symptoms and colorectal
cancer, these analyses were based on the 159 patients
found to have cancer and the 7577 who had no can-
cer or adenoma.
The distribution of patients across the five categories
relating to how seriously patients took their symptoms,
and the prevalence of cancer within each category was
calculated. The five categories were reduced to three for
subsequent analyses by combining “a lot less seriously”
with “less seriously” and also combining “much more
seriously” with “more seriously”. The relative frequency
of responses and the prevalence of cancer for these three
categories were computed separately for males and
females, according to: age (<50, 50–59, 60–69, 70+
years); anaemia (present vs absent); and the presence
and frequency of symptoms (rectal bleeding, rectal mucus
and abdominal pain). Informed by our previously publis-
hed model [12], abdominal pain and mucus symptoms
were coded as <12 months duration, occurring weekly;
<12 months duration, occurring monthly/occasionally; or
none/>12 months duration. Bleeding was coded as
<12months duration, occurring weekly; <12 months dur-
ation, occur-ring monthly/occasionally; or no bleeding />12
months duration.
Logistic regression was used to assess the association bet-
ween how seriously patients took their symptoms and colo-
rectal cancer, both univariately and also adjusted for vari-
ables included in the previously developed multivariable
model to predict the presence of cancer (age, gender, previ-
ous colonoscopy, history of diverticular disease, aspirin and
non-steroidal inflammatory drug use, anaemia, rectal bleed-
ing, rectal mucus and abdominal pain) [12]. Although one
objective was to assess the incremental gain of adding how
seriously patients took their symptoms to the established
prediction model, interactions between this variable and
age, gender and each of the symptoms listed above were
also investigated. The likelihood ratio test was used to
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used as the criterion for significance.
All statistical analyses were undertaken using SAS stat-
istical software [15].Reliability of the question on symptom perception
The reliability of the question relating to symptom
perception was evaluated using the same method-
ology and the same patients as the published evalu-
ation of the reliability of the questions relating to
symptoms in the questionnaire [14]. Patient-patient
agreement (reproducibility) was assessed in a group
of 138 patients who completed the self-administered
questionnaire immediately prior to their consultation
with the doctor, and who were mailed the same
questionnaire to complete an average of 4.2 weeks
later (median 3.3 weeks).
Patient–doctor agreement was assessed in another
group of 108 patients by comparing the patient’s ques-
tionnaire response to how seriously they took their
symptoms prior to the consultation with their specialist’s
response to the same question based on their perception
of the patient during the consultation. The specialist was
blinded to the patient’s response.
For both patient-patient and patient-doctor agreement,
the proportion of responses showing absolute agreement
across all five categories was computed. The weighted
kappa statistic (κ), using linear weights, was computed.
The McNemar test was used to assess evidence of a
systematic direction for disagreements.Ethics committee approval
The study received approval from the Ethics Committees
of the University of Sydney, Central Sydney Area Health
Service (both CRGH and Central Zones), Northern Sydney
and Central Coast, Western Sydney Area Health Service







A lot less seriously 362 4.7
Less seriously 976 12.8
Same [Referent Group] 4,115 53.9
More seriously 1,799 23.6
A lot more seriously 382 5.0
Total 7634 100
*Self assessment, compared to others of the same age.
**p < 0.001; p-value for trend <0.0001, p-value for departures from linear trend = 0.0Results
Of the 7,736 patients in the study, only 102 did not an-
swer the question relating to symptom perception and
were excluded from further analysis. About half reported
that they took their symptoms with the same seriousness
as other people. Of the remaining patients, those who
said they took their symptoms more seriously were al-
most twice as numerous as those who said took their
symptoms less seriously (Table 1). The pattern of
responses was similar for males and females: 53.1% of
males and 54.6% of females reported taking their
symptoms as seriously as others, 30.1% of males and
27.3% of females took their symptoms more seriously,
and 16.8% of males and 18.2% of females took the
symptoms less seriously than others. Increasing age
was accompanied by a smaller percentage of people
who reported taking symptoms more seriously than
others, especially in females (p for trend p < 0.001 for
females and p = 0.03 for males; Figure 1 and detailed
table in Additional file 1: Table S1).
The percentage of patients reporting abdominal pain
decreased as the seriousness with which patients took
their symptoms increased (Figure 2); this trend was
evident for both men (p for trend =0.002) and women (p
for trend =0.002). For men, the percentage reporting ab-
dominal pain decreased from 20.1% in those who took
their symptoms less seriously to 14.2% in those who
took symptoms more seriously; the corresponding per-
centages for females are 24.3% and 18.4%. The percent-
age of women reporting anaemia also decreased as the
seriousness with which they took their symptoms
increased (Figure 2, p for trend = 0.014) but no such
trend was evident for males (p = 0. 2). There was no evi-
dence of association between how seriously patients took
their symptoms and how likely they were to report rectal
bleeding or mucus. Details are given in Additional file 2:
Table S2.
How seriously patients reported they took any symp-
toms was associated with colorectal cancer (Table 1).er prevalence, for all five symptom perception categories
Cancer Unadjusted
OR (95% CI)**Cases Prevalence%
10 2.8 1.38 (0.71, 2.68)
39 4.0 2.02 (1.37, 2.98)
83 2.0 1.00
22 1.2 0.60 (0.38, 0.97)
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Figure 1 Age-specific percent of patients who report that they took any symptoms more, the same or less seriously than others.
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using those who reported taking any symptoms with the
same seriousness as others as the referent group, those
who reported that they took any symptoms less seriously
had almost a 2-fold higher prevalence of colorectal
cancer (OR 1.85, 95%CI: 1.29, 2.64) compared to the
referent group, whereas those who reported taking any
symptoms more seriously had about half the prevalence
(OR 0.56, 95%CI: 0.36, 0.88) compared with the referent
group (Table 2). Hence, those who reported taking their
symptoms less seriously were 3.28 (=1.85/0.56) (95%CI:
2.02, 5.33) times more likely to have cancer than those
to who took their symptoms more seriously. Overall, the
cancer prevalence in males was inversely related to how
seriously they took their symptoms relative to others:
1.2%, 2.4%, and 4.7% corresponding to “more seriously”,
“same” and “less seriously”. For females, the correspond-
ing cancer prevalences were 1.1%, 1.7% and 2.8%. TheMale
Symptoms Symptom Perception
Anaemia present
Mucus weekly <12 months
Bleeding monthly <12 months
Bleeding weekly <12 months


















Figure 2 Percentage of patients reporting symptoms, by whether the
others.prevalence gradient was evident in almost all age groups
(Figure 3, and details are given in Additional file 3:
Table S3). Although the gradient seemed strongest in
men in their 50s and 60s, this was easily explained by
chance with p = 0.57 for the interaction term for age
group by sex by how seriously patients took any
symptoms in the multivariable model.
Based on the data from this study, we have previously
developed a multivariable prediction model for the
presence of cancer based on sociodemographic variables
(age, gender), medical history (previous colonoscopy,
history of diverticular disease, use of aspirin or non-
steroidal anti-inflammatory medication) and symptoms
(rectal bleeding, rectal mucus, abdominal pain, and an-
aemia) [12]. The model was demonstrated to have
good discrimination with an area under the Receiver
Operating Characteristic curve of 0.85 [7]. For these




0 5 10 15 20 25
y take any symptoms more, the same or less seriously than
Table 2 Unadjusted and adjusted odds of cancer for the
three groupings of symptom perception






Less/lot less seriously 1.85 (1.29, 2.64) 1.47 (1.00, 2.14)
Same [Referent Group] 1.00 1.00
More/lot more seriously 0.56 (0.36, 0.88) 0.79 (0.50, 1.27)
P-value <0.001** 0.04
# Adjusted for age, sex, previous colonoscopy, NSAID use, aspirin use,
anaemia, diverticulitis, abdominal pain, bleeding and mucus.
** p-value for trend <0.0001, p-value for departures from linear trend = 0.242.
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12 months. Adding the three category covariate for
how seriously patients took any symptoms to this
model showed that patients’ perception of their
symptoms remained significantly associated with
colorectal cancer (full model results are presented in
Table 3). The odds ratio gradient was less dramatic
after adjustment (Table 2, p = 0.04). After adjustment,
patients who took their symptoms less seriously had
an odds ratio of 1.47 (95%CI: 1.00, 2.14) compared
to the unadjusted estimate of 1.85. Contrasting
patients who take their symptoms less serious than
others with patients who take their symptoms more
seriously than others, the adjusted odds ratio was
1.85 (95%CI: 1.11, 3.09) compared with the un-
adjusted estimate of 3.28. There was no statistical
evidence of interaction between symptom perception
and any of the symptoms included in the model.
The prevalence of cancer was highest in those
patients who took their symptoms less seriously than
others for people both with and without each symp-
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Figure 3 Effect of age and gender on cancer rate in each symptoms pReliability of the question on how seriously people
thought they took any symptom
In the patient-patient comparison based on the original
5-category responses, there was complete agreement in
70% and agreement within 1 category in 92% of patients
(Table 5). Kappa was 57% (95% CI 43-65%), indicating
substantial agreement [16]. There was no significant
difference in the direction of the disagreements between
the first and second patient completion of the question
(McNemar’s test: p = 0.54).
In the patient-doctor comparison, there was complete
agreement in 66% and agreement within 1 category in
92% of responses (Table 6). Kappa was 48% (95% CI 34-
61%), indicating moderate agreement [16]. For the
disagreements, there was no systematic effect in the
direction of the responses between doctors and patients
(McNemar’s test: p = 0.87).
Discussion
In our study, patients who take any symptoms less ser-
iously than others have an almost 2-fold higher preva-
lence of cancer (OR 1.85, 95%CI: 1.29, 2.64) than those
who take their symptoms with the same seriousness as
others, and a more than a 3-fold higher prevalence of
cancer (OR= 3.28, 95%CI: 2.02, 5.33) than those who
take their symptoms more seriously than others. Even if
adjustment is made for a wide range of other predictors
of colorectal cancer, the effects are still almost 1.5 and
2-fold respectively. An increase in prevalence is apparent
in all age groups, in males and females and also in
people with, and without, symptoms. The assessment of
how seriously people took their symptoms was based on
a question which is reliable and easy to answer which
only a very small percent of patients did not complete.8 9 10
Female
Percent with Cancer
0 1 2 3 4 5 6 7 8 9 10
erception group.
Table 3 Multivariable model results




Yes 0.24 (0.16, 0.35) <0.001
Age Group < 50 years (referent group) 1.00 <0.001
50 – 59 years 7.09 (3.44, 14.61)
60 – 69 years 15.02 (7.36, 30.64)
70 years or more 25.10 (12.28, 51.31)
Anaemia No (referent group) 1.00
Yes 3.59 (2.40, 5.38) <0.001
NSAID use No (referent group) 1.00
Yes 0.35 (0.16, 0.76) 0.002
Aspirin use No (referent group) 1.00
Yes 0.58 (0.37, 0.93) 0.017
Diverticulitis None (ref group) 1.00
Yes 0.38 (0.17, 0.85) 0.008
Sex Male (referent group) 1.00
Female 0.68 (0.48, 0.95) 0.023
Abdominal Pain None or occur less frequently than
weekly or present > 12 months (referent group)
1.00
Occurs weekly; and present <12 months 2.28 (1.60, 3.26) <0.001
Bleeding None or present >12 months (referent group) 1.00
Occurs monthly/occasionally; and
present <12 months
2.07 (1.33, 3.24) <0.001
Occurs weekly and present <12 months 5.56 (3.63, 8.53)
Mucus None or occur less frequently than weekly or
present > 12 months (referent group)
1.00
Occurs weekly and present <12 months 2.65 (1.49, 4.73) 0.002
How seriously take symptoms Less seriously 1.47 (1.00, 2.14) 0.044
Same (referent group) 1.00
More seriously 0.79 (0.50, 1.27)
NSAID = non-steroidal anti-inflammatory drug.
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tion to assess how seriously people reported they took
symptoms and testing predictive validity in a large high
quality study of an important clinical disease. The ques-
tion is asked in a general way and is not restricted to
any particular set of symptoms or disease. High quality
of the predictive validity study was assured by several
features. The data were collected prospectively with the
question completed before disease was identified, all
patients underwent colonoscopy with a caecal intubation
rate of 98% and all lesions were examined for pathology.
The weakness of our study is that we investigated only
one condition – colorectal cancer – so we cannot be cer-
tain that the results would be as striking for other clinical
outcomes. That can be readily assessed by researchers add-
ing the question we used to their studies.We are not aware of any previous tool that encapsu-
lates how seriously patients take their symptom in a sin-
gle question. It is possible that the question relates to
stoicism, on which there is some research. Murray et al.
showed that the Liverpool Stoicisim Scale has adequate
reliability. However, this requires a 20-item question-
naire. They found that stoicism was associated with
lower reported quality of life though they did not ex-
plore whether serious clinical diagnoses are more com-
mon in stoical people. More generally, they point out
that there is very little research on stoicism [17]. Miller
has shown that individual differences in health–seeking
behaviour and health status are influenced by whether
people typically scan for threat-level information (high
monitors) or ignore threat-relevant information (low
monitors) [7]. High monitors, who are assessed by their
MaleSymptoms Perception
                        Less
                        Same
                        More
Total
                        Less
        Absent          Same
                        More
                        Less
        Present         Same
                        More
Anaemia
                        Less
        None or >12mths Same
                        More
                        Less
        Weekly <12mths  Same
                        More
Mucus
                        Less
        None or >12mths Same
                        More
                        Less
        Monthly <12mths Same
                        More
                        Less
        Weekly <12mths  Same
                        More
Bleeding
                        Less
        None or >12mths Same
                        More
                        Less
        Weekly <12mths  Same
                        More
Abdominal Pain
Percent with Cancer
0 2 4 6 8 10 12 14
Female
Percent with Cancer
0 2 4 6 8 10 12 14
Figure 4 Cancer rate for symptom in each symptom perception group.
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plain about these as much as low monitors. However,
measurement of whether people are high or low moni-
tors is by completion of 32 responses to 4 imaginary,
stress-invoking scenarios [18]. These measures differ
from ours in concept, in that they have been developed
for use in people already labelled as having a disease and
in their complexity.
We have shown that our simple single question
can predict disease, prior to diagnosis, and irrespect-
ive of the presence of symptoms. Our single ques-
tion does not measure or evaluate the underlying
constructs and mechanisms that may explain why a
person takes their symptoms as seriously as they do;
the question effectively provides an assessment of
how seriously a person takes their symptoms, and
links this to patient outcomes. We are not aware of
any other studies that have used a single question in
this way.Our results are based on a clinical population – all
patients had been referred for specialist consultation and
subsequently underwent colonoscopy, although the ques-
tion was answered prior to this. The presence of bowel
symptoms is a common reason for seeking medical atten-
tion [19]. In our study 6 of the symptoms were reported as
present by more than 30% of patients. Our cancer detec-
tion rate is 1.9%, suggesting it is not a high-risk referred
population. Although the population is not highly selected,
we think that our finding is not a feature of a general
population, but rather reflects who seeks medical help.
One way of explaining our findings is by considering a
hypothetical scenario loosely based on our results. Im-
agine that the colorectal cancer prevalence is about 3%
in people going for colonoscopy who report taking
symptoms less seriously than others; one can represent
this as 3 cancers in 100 people. It seems likely that
people who take their symptoms more seriously than
others access health services for minor symptoms that
Table 4 Prevalence of cancer within groups defined by the seriousness with which patients take their symptoms, for
males and females separately
Males Females
Less Same More Less Same More




11 9.2 120 19 6.0 315 5 3.3 152 8 4.4 180 13 2.7 477 0 0.0 205








6 8.0 75 4 1.5 261 5 3.3 151 7 6.1 115 5 1.4 366 2 1.1 176




3 13.6 22 4 8.2 49 3 10.0 30 3 7.1 42 4 3.6 110 1 2.0 51
Everything else 25 4.4 574 42 2.3 1834 10 1.0 1037 18 2.6 700 33 1.6 2122 11 1.0 1063
Anaemia
Present 4 7.4 54 4 7.4 54 3 3.8 79 6 5.3 113 13 4.7 275 2 1.6 125
Absent 24 4.4 542 35 2.0 1754 10 1.0 988 15 2.4 629 24 1.2 1957 10 1.0 989
Total 28 4.7 596 46 2.4 1883 13 1.2 1067 21 2.8 742 37 1.7 2232 12 1.1 1114
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ferred for colonoscopy, this might add an extra 100
people to the pool of patients investigated, without
adding any more cancers, so that the cancer preva-
lence is now only 1.5%.
Another way of explaining our findings is that
people who take their symptoms more seriously
present for colonoscopy earlier or more frequently
than those who take their symptoms less seriously,
allowing polyps to be detected and removed prevent-
ing their progression to colorectal cancer.
One might expect the effect on outcomes of how
seriously people take their symptoms to disappearTable 5 Patient-patient responses to symptom question






Less Same More Much
more
Total
A lot less 1 1 2 1 0 5
Less 1 8 2 2 0 13
Same 1 3 41 6 0 51
More 1 0 4 15 3 22
Much
more
1 0 0 2 5 8
Total 5 12 49 26 8 100%once the effect of symptom perception is added to a
model containing predictive bowel symptoms. The
fact that the gradient of risk for our symptom percep-
tion question is diluted but still evident suggests that
the effect must be partly mediated by factors outside
those measured which are important in people’s
health-seeking behaviour.
Conclusion
Our study has shown that the question presented here is a
reproducible tool to assess how seriously a patient takes
any symptoms and that the assessment of how seriously
patients take symptoms is a useful addition to theTable 6 Patient-doctor responses to symptom question






Less Same More Much
more
Total
A lot less 0 4 2 0 1 7
Less 0 6 2 2 0 10
Same 0 5 45 4 0 55
More 0 1 6 12 3 22
Much
more
0 0 3 2 2 7
Total 0 17 58 20 6 100%
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sessment of patients. Our study needs to be repeated in
other populations and with other disease outcomes. If the
result is replicable, it suggests that doctors would be wise to
have a heightened appreciation that in those who take
symptoms less seriously than others, there may be
increased risk of serious pathology.
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Additional file 1: Table S1. Distribution of how seriously people take
their symptoms by age group, for males and females. Table showing
number (and percentage) of males and females in each of the age
groups <50, 50-59, 60-69 and >70 years shown by whether they take
their symptoms less, the same as or more seriously than others.
Additional file 2: Table S2. Distribution of the severity of symptoms
within groups defined by the seriousness with which patients take their
symptoms, for males and females separately. Table showing number (and
percentage) of males and females, grouped by severity of each of
abdominal pain, rectal bleeding, much and anaemia, shown by whether
they take their symptoms less, the same as or more seriously than others.
Additional file 3 Table S3. Prevalence of cancer within age groups
defined by the seriousness with which patients take their symptoms, for
males and females separately. Table showing number (and percentage)
of males and females with colorectal cancer in each of the age groups
<50, 50-59, 60-69 and >70 years shown by whether they take their
symptoms less, the same as or more seriously than others.
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